This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

JCI online early table of contents: Sept. 8, 2009

September 8th, 2009

EDITOR'S PICK: Engineered human fusion protein protects against HIV-1 infection

In 2004, Jeremy Luban and colleagues from the University of Geneva, Switzerland, reported that New World owl monkeys (Aotus genus) make a fusion protein - AoT5Cyp - that potently blocks HIV-1 infection. The human genome encodes the equivalent of the 2 components of AoT5Cyp (i.e., TRIM5 and cyclophilin A), but humans unfortunately do not make the T5Cyp fusion protein. In their new study in the Journal of Clinical Investigation, Luban et al. have engineered a human HIV-1 inhibitor modeled after AoT5Cyp, by fusing human cyclophilin A to human TRIM5 (hT5Cyp). The human fusion protein blocked HIV-1 infection of human macrophage and T cell lines, without disrupting normal cell function. Mice engineered to lack B, T, and NK immune cells (to ensure that the animals do not reject grafts of human material) were then engrafted with human CD4+ T cells engineered to contain hT5Cyp. HIV-1 replication was potently inhibited in these animals. The authors concluded that hT5Cyp is a robust inhibitor of HIV-1 replication and a promising anti-HIV-1 gene therapy candidate.

TITLE: Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components

AUTHOR CONTACT:

Jeremy Luban

University of Geneva, Geneva, Switzerland.

Phone: 41-22-379-5720; Fax: 41-22-379-5702; E-mail: jeremy.luban@unige.ch

View the PDF of this article at: https://www.the-jci.org/article.php?id=39354


ONCOLOGY: TNF-alpha promotes ovarian tumors with a little help from friends TNFR1 and IL-17

TITLE: The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans

AUTHOR CONTACT:

Thorsten Hagemann

Queen Mary University of London, London, United Kingdom.

Phone: 44-20-78825795; Fax: 44-20-78826110; E-mail: t.hagemann@qmul.ac.uk

View the PDF of this article at: https://www.the-jci.org/article.php?id=39065


CARDIOLOGY: Cdc42 restrains hypertrophy in the heart

TITLE: Cdc42 is an antihypertrophic molecular switch in the mouse heart

AUTHOR CONTACT:

Jeffery D. Molkentin

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Phone: (513) 636-3557; Fax: (513) 636-5958; E-mail: jeff.molkentin@cchmc.org

View the PDF of this article at: https://www.the-jci.org/article.php?id=37694


CELL BIOLOGY: Kinase CAMKII links multiple mechanisms of stress-induced cell death

TITLE: Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways.

AUTHOR CONTACT:

Ira Tabas

Columbia University, New York, New York, USA.

Phone: (212) 305-9430; Fax: (212) 305-4834; E-mail: iat1@columbia.edu

View the PDF of this article at: https://www.the-jci.org/article.php?id=38857

Source: Journal of Clinical Investigation

Citation: JCI online early table of contents: Sept. 8, 2009 (2009, September 8) retrieved 23 August 2026 from https://sciencex.com/wire-news/13886006/jci-online-early-table-of-contents-sept-8-2009.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.